Skip to main content
Displaying 13 - 24 of 39
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Novo Nordisk: Navigating MASH patient care (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Personalised management of MASH (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Updates on the essence of MASH (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Takeda: "Alpha-1 antitrypsin deficiency (AATD) - Associated liver disease: More common than you may think" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Adults with Pi*MZ or Pi*ZZ genotype: Cases review
Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction to AATD and AATD-associated liver disease
Webcasts
View
Metabolism, Alcohol & Toxicity
Diagnosis of AATD-associated liver disease with a review of pediatric cases
Webcasts
View
Metabolism, Alcohol & Toxicity
Unmet needs and future outlook for patients with AATD-associated liver disease
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and introduction
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Page
4
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy